Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 17, 2015

Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury

Your doctor will need to create a followup study on this. Or a study sponsored by our fucking failures of stroke associations.

Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury`

McAllister TW1, Zafonte R2, Jain S3, Flashman LA4, George MS5, Grant GA6, He F3, Lohr JB7, Andaluz N8, Summerall L9, Paulus MP10, Raman R3, Stein MB11,12.

Author information

Abstract

We report findings from a 12-week randomized double-blind placebo-controlled trial of methylphenidate or galantamine to treat emotional and cognitive complaints in individuals (N=32) with a history of PTSD, TBI, or both conditions. In this small pilot study, methylphenidate treatment was associated with clinically meaningful and statistically significant improvement compared to placebo on the primary outcome, a measure of cognitive complaints (Ruff Neurobehavioral Inventory - Postmorbid Cognitive Scale), as well as on the secondary outcomes reflecting postconcussive (Rivermead Postconcussive Symptom Questionnaire) and posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist). Treatment was well tolerated. These results suggest the need for a larger RCT to replicate and confirm these findings. Design considerations for such a trial should include the need for multiple sites to facilitate adequate recruitment and extension of the treatment and follow-up periods.Neuropsychopharmacology accepted article preview online, 11 September 2015. doi:10.1038/npp.2015.282.
Posted by at
Labels: , , , , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)